Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP467198.RAxdtXEOnq-tFRBEQJP0EzO-VqVl-ebyc0hGsDsRgRiqY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP467198.RAxdtXEOnq-tFRBEQJP0EzO-VqVl-ebyc0hGsDsRgRiqY130_assertion type Assertion NP467198.RAxdtXEOnq-tFRBEQJP0EzO-VqVl-ebyc0hGsDsRgRiqY130_head.
- NP467198.RAxdtXEOnq-tFRBEQJP0EzO-VqVl-ebyc0hGsDsRgRiqY130_assertion description "[If p53 mutations develop frequently in relapsed neuroblastoma, cytotoxic agents more sensitive to mutant p53 might be more effective at relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP467198.RAxdtXEOnq-tFRBEQJP0EzO-VqVl-ebyc0hGsDsRgRiqY130_provenance.
- NP467198.RAxdtXEOnq-tFRBEQJP0EzO-VqVl-ebyc0hGsDsRgRiqY130_assertion evidence source_evidence_literature NP467198.RAxdtXEOnq-tFRBEQJP0EzO-VqVl-ebyc0hGsDsRgRiqY130_provenance.
- NP467198.RAxdtXEOnq-tFRBEQJP0EzO-VqVl-ebyc0hGsDsRgRiqY130_assertion SIO_000772 11196202 NP467198.RAxdtXEOnq-tFRBEQJP0EzO-VqVl-ebyc0hGsDsRgRiqY130_provenance.
- NP467198.RAxdtXEOnq-tFRBEQJP0EzO-VqVl-ebyc0hGsDsRgRiqY130_assertion wasDerivedFrom befree-20140225 NP467198.RAxdtXEOnq-tFRBEQJP0EzO-VqVl-ebyc0hGsDsRgRiqY130_provenance.
- NP467198.RAxdtXEOnq-tFRBEQJP0EzO-VqVl-ebyc0hGsDsRgRiqY130_assertion wasGeneratedBy ECO_0000203 NP467198.RAxdtXEOnq-tFRBEQJP0EzO-VqVl-ebyc0hGsDsRgRiqY130_provenance.